1. Suarez S, Abend A, Hoffelder T, Leblond D, Delvadia P, Kovacs E, et al. In vitro dissolution profiles similarity assessment in support of drug product quality: what, how, when—workshop summary report. AAPS J. 2020;22(4):74.
2. Hoffelder T, Leblond D, Van Alstine L, Diaz DA, Suarez-Sharp S, Witkowski K, et al. Dissolution profile similarity analyses-statistical principles, methods and considerations. AAPS J. 2022;24(3):54.
3. Abend A, Zhang L, Fredro-Kumbaradzi E, Hoffelder T, Cohen M, Anand O, et al. Current approaches for dissolution similarity assessment, requirements, and global expectations. AAPS J. 2022;24(3):50.
4. Nosal R. The Value of Similarity Testing in Drug Product Development. In: In vitro Dissolution Profiles Similarity Assessment in Support of Drug Product Quality Workshop. Baltimore, MD; 2019. Available at:
https://www.pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/dissolution-similarity/nosal-slides.pdf.
5. European Medicines Agency. Committee for medicinal products for human use. Guideline on the investigation of bioequivalence CPMP/EWP/QWP/1401/98 Rev.1/Corr**. EMA guidance. 2010. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf